Publication Details
Issue: Vol 4, No 2 (2023)
Pages: 446-450
ISSN: 2660-4159

Abstract

Most researchers support the important role of incretins, particularly glucagon-like peptide-1 in improving metabolic control in patients with type 2 diabetes after bariatric operations, mostly involving shunting. A positive effect of bariatric surgery for type 2 diabetes is known from numerous publications on the results of surgical treatment of morbid obesity and in this review we try to analyze the mechanisms of this effect.     

Keywords
morbid obesity type 2 diabetes bariatric surgery incretins.